Merck & Co. (MRK)
(Delayed Data from NYSE)
$128.42 USD
+2.88 (2.29%)
Updated Jun 3, 2024 04:00 PM ET
Pre-Market: $127.93 -0.49 (-0.38%) 9:24 AM ET
3-Hold of 5 3
C Value A Growth B Momentum B VGM
Brokerage Reports
Merck & Co., Inc. [MRK]
Reports for Purchase
Showing records 361 - 380 ( 394 total )
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Specialty Pharmaceuticals Short Interest Analysis
Provider: AURIGA USA
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Company Leveraged 2% Fourth Quarter Sales Growth into a Double-Digit Earnings Gain
Provider: J.J.B. Hilliard, W.L. Lyons
Analyst: O'NEIL S
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Technical Takeaways: Bullish Sector Rotation Continues; Pharmaceutical ETF may be Topping.
Provider: AURIGA USA
Analyst: ALBANESE G
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Technical Takeaways: Bullish Sector Rotation Continues; Pharmaceutical ETF may be Topping.
Provider: AURIGA USA
Analyst: ALBANESE G
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Broad-based Worldwide Third Quarter Revenue Growth
Provider: J.J.B. Hilliard, W.L. Lyons
Analyst: O'NEIL S
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Management Pursuing Additional Cost Savings to Sustain Earnings
Provider: J.J.B. Hilliard, W.L. Lyons
Analyst: O'NEIL S
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Company: Merck & Co., Inc.
Industry: Large Cap Pharmaceuticals
Topline pressure likely to continue, with key drugs, such as Cozaar facing patent expiry....
Provider: FIRST GLOBAL
Analyst: THOMAS K